Overview

Combined Use of Teriparatide and Raloxifene in Postmenopausal Women With Osteoporosis

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare treatment with both teriparatide and raloxifene with teriparatide alone. The study will evaluate any side effects that may be associated with the two drugs and may help to determine whether teriparatide and raloxifene together can help patients with osteoporosis more than teriparatide alone.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Raloxifene Hydrochloride
Teriparatide